Minocycline induced autoimmune hepatitis and systemic lupus erythematosus-like syndrome

British Medical Journal

Volumn 312, Issue 7024, 1996, Pages 169-172

  Gough, Andrew ^a   Chapman, Stephen ^b   Wagstaff, Kate ^c   Emery, Paul ^d   Elias, Elwyn ^e  

^a HARROGATE DISTRICT HOSPITAL   (United Kingdom)

^b KEELE UNIVERSITY   (United Kingdom)

^c SELLY OAK HOSPITAL   (United Kingdom)

^d UNIVERSITY OF LEEDS   (United Kingdom)

^e QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; MINOCYCLINE;

ACNE; ADOLESCENT; ADULT; ANEMIA; ANTIBIOTIC RESISTANCE; ARTHRALGIA; ARTHRITIS; ARTICLE; AUTOIMMUNE HEPATITIS; AUTOIMMUNITY; CLINICAL ARTICLE; COMPLICATION; DERMATITIS; DRUG FATALITY; DRUG SAFETY; EARLY DIAGNOSIS; FEMALE; FEVER; HEADACHE; HUMAN; HUMAN CELL; JAUNDICE; KIDNEY DISEASE; LIVER TRANSPLANTATION; MALAISE; MALE; MYALGIA; ORAL DRUG ADMINISTRATION; PANCYTOPENIA; POLYARTHRITIS; PRIORITY JOURNAL; RASH; RECURRENT DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS; TASTE DISORDER; VERTIGO;

EID: 0030032533     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.312.7024.169     Document Type: Article

References (23)

1. Dollery C, ed. Therapeutic drugs. London: Churchill Livingstone, 1991.
2. Healy E, Simpson N. Acne vulgaris. BMJ 1994;308:831-3.
3. Eady EA, Jones CE, Tipper JL, Cove JH, Cunliffe WJ, Layton AM. Antibiotic resistant propionibacteria in acne: need for policies to modify antibiotic usuge. BMJ 1993:306:555-6.
4. Domz CA, McNamara DH, Holzapfel HF. Tetracycline provocation in lupus crythematosus. Ann Intern Med 1959;50:1217-26.
5. Matsuura T, Shimizu Y, Fujimoto H, Miyazaki T, Kano S. Minocycline related lupus. Lancet 1992;340:1553.
6. Otero M, Goodpasture HC. Pulmonary infiltrates and minocycline. JAMA 1983;250:2602.
7. Puyana J, Urena V, Quirce S, Fernandez-Rivas M, Cuevas M, Fraj J. Serum sickness-like syndrome associated with minocycline therapy. Allergy 1990; 45:313-5.
8. Gorard DA. Late-onset drug fever associated with minocycline. Postgrad Med J 1990;66:404-5.
9. Davies MG, Kersey PJW. Acute hepatitis and exfoliative dermatitis associated with minocycline. BMJ 1989;298:1523-4.
10. Byrne PAC, Williams BD, Pritchard MH. Minocycline related lupus. Br J Rheum 1994;33:674-6.
11. Rutenbery AM, Pinkes S. Hepatotoxicity of intravenous aurcomycin. N Engl J Med 1952;247:797-800.
12. Schultz JC, Adamson JS Jr, Workman WW, Norman TD. Fatal liver disease and intravenous administration of tetracycline in high dosage. N Eng J Med 1963;269:999-1004.
13. Peters RL, Edmondson HA, Mikkelsen WP, Tatter D. Tetracycline-induced fatty liver in non-pregnant patients. Am J Surg 1967;113:622-32.
14. Robinson MJ, Rywlin AM. Tetracycline associated fatty liver in the male. Am J Digest Dis 1970;15:857-62.
15. Burette A, Finet C, Pripogine T, DeRoy G, Deltenre M. Acute hepatic injury associated with minocycline. Arch Int Med 1984;144:1491-2.
16. Boudreaux JP, Hayes DH, Mizrahi S, Hussey J, Regenstein F, Balarr L. Fulminant hepatic failure, hepatorenal syndrome and necrotising pancreatitis after minocycline hepatotoxicity. Transplant Proc 1993;25:1873.
17. Bǒcker R, Estler CJ, Ludewig-Sandig D. Evaluation of the hepatotoxic potential of minocycline. Antimicrob Agents Chemother 1991;35:1434-6.
18. MacDonald H, Kelly RG, Allen ES, Noble JF, Kanegis LA. Pharmacokinetic studies on minocycline in man. Clin Pharmacol Ther 1973;14;852-61.
19. Nelis HJCF, De Leenheer AP. Unique metabolic fate of a tetracycline (minocycline). Lancet 1981;11:938.
20. Min ID, Burke PA, Lewis WD, Jenkins RL. Acute hepatic failure associated with oral minocycline: a case report. Pharmacotherapy 1992;12:68-72.
21. Johnson PJ, McFarlane IG. Meeting report: International Autoimmune Hepatitis Group. Hepatology 1993;18:998-1005.
22. Knitzer RH, Needleman BW. Musculoskeletal syndromes associated with acne. Semin Arthritis Rheum 1991;2:247-55.
23. Soldinyer AM. Drug-related lupus: clinical and etiological considerations, Rheum Clin North Am 1988;14:187-202.